Imricor Medical Systems, Inc. (ASX:IMR)
Australia · Delayed Price · Currency is AUD 1.970
+0.040 (2.07%)
Aug 28, 2026, 4:10 PM AEST
Imricor Medical Systems Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 0.12 | 0.29 | 0.96 | 0.62 | 0.82 | 0.7 |
Revenue Growth | -83.96% | -69.53% | 55.86% | -24.56% | 17.20% | -0.84% |
Gross Profit Gross Profit Growth | -2.79 | -2.03 | -0.92 | -1.12 | -1.53 | -1.9 |
Operating Income Operating Income Growth | -27.41 | -22.79 | -16.3 | -16.86 | -17.26 | -20.26 |
Net Income Net Income Growth | -37.32 | -25.32 | -29.69 | -22.63 | -17.36 | -19.73 |
Earnings Per Share EPS Growth | -0.12 | -0.08 | -0.13 | -0.14 | -0.12 | -0.15 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Germany Germany Growth | 0.1 | 0.11 | 0.17 | 0.16 | 0.35 |
Hungary Hungary Growth | 0.03 | 0.02 | 0.18 | - | - |
Netherlands Netherlands Growth | -0.01 | 0.16 | 0.1 | 0.2 | 0.34 |
United States (u.s) United States (u.s) Growth | - | - | 0.12 | 0.13 | 0.05 |
Other Countries Other Countries Growth | - | - | 0.08 | - | 0.07 |
Switzerland Switzerland Growth | - | - | 0.17 | - | - |
Qatar Qatar Growth | - | - | 0.16 | - | - |
Total Total Growth | 0.12 | 0.29 | 0.96 | 0.62 | 0.82 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 67.46 | 40.78 | 15.71 | 0.83 | 5.69 | 18.52 |
Total Debt Total Debt Growth | 34.02 | 25.97 | 21.21 | 10.71 | 4.45 | 1.74 |
Net Cash (Debt) Net Cash Growth | 33.44 | 14.81 | -5.51 | -9.88 | 1.24 | 16.78 |
Net Cash Growth | 30.94% | - | - | - | -92.60% | -25.90% |
Net Cash Per Share Net Cash Per Share Growth | 0.10 | 0.05 | -0.02 | -0.06 | 0.01 | 0.13 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -23.99 | -19.08 | -15.57 | -12.98 | -16.51 | -17.49 |
Capital Expenditures CapEx Growth | -0.8 | -0.43 | -0.08 | -0.08 | -0.24 | -0.63 |
Free Cash Flow Free Cash Flow Growth | -24.79 | -19.52 | -15.65 | -13.06 | -16.75 | -18.11 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | - | - | -96.32% | -181.27% | -187.10% | -272.30% |
Operating Margin | -22830.48% | -7796.87% | -1698.60% | -2738.12% | -2115.18% | -2909.72% |
Pretax Margin | -31076.71% | -8661.57% | -3094.86% | -3675.61% | -2126.96% | -2834.05% |
Profit Margin | -31076.71% | -8661.58% | -3094.86% | -3675.61% | -2126.96% | -2834.05% |
FCF Margin | -20647.92% | -6676.31% | -1631.38% | -2121.66% | -2052.56% | -2601.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 4069.73 | 1120.53 | 237.01 | 106.62 | 46.01 | 150.33 |